CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma

Norge Nyheter Nyheter

CSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma
Norge Siste Nytt,Norge Overskrifter
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

Australia's CSL makes $11.7 billion cash offer for Switzerland's Vifor Pharma

By Stuart Condie SYDNEY--Australian biopharmaceutical company CSL Ltd. said it had made an all-cash offer for Vifor Pharma Ltd. that values the Swiss pharmaceutical developer's equity at US$11.7 billion.

CSL on Tuesday said it would partially fund the acquisition with a fully underwritten 6.3 billion Australian dollars share placement and a share purchase plan of up to A$750 million. It will also tap US$6.0 billion in existing cash and a combination of new and existing debt. CSL said it had made a public tender offer of US$179.25 a share. The offer had been unanimously recommended by Vifor's directors, it said.

Vaccine and blood-products maker CSL, the second-largest ASX-listed company by market capitalization, has requested that its shares be placed in a trading halt until Thursday for the capital raising. CSL said Vifor's portfolio focused on renal disease and iron deficiency would complement its existing therapeutic focus areas, while the Australian company's global reach, R&D capabilities and resources would augment the delivery of Vifor Pharma products.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

MarketWatch /  🏆 3. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Vifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.
Les mer »

Vifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma shares jump 15% as takeover talks with CSL confirmedVifor Pharma's shares surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL both confirmed they were talking about a potential merger.
Les mer »

BOJ offers huge cash injection to combat rising short-term ratesBOJ offers huge cash injection to combat rising short-term ratesThe Bank of Japan offered to pump a combined $97 billion into markets through temporary government bond purchases in a two-day effort to counter a rise in short-term interest rates.
Les mer »

China offers U.S. humanitarian assistance following Kentucky tornado disasterChina offers U.S. humanitarian assistance following Kentucky tornado disaster'We expressed our condolences and willingness to provide emergency humanitarian help to the affected people according to the needs of the U.S. side.'
Les mer »

SenseTime Halts Hong Kong IPO After Being Blacklisted by U.S.SenseTime Halts Hong Kong IPO After Being Blacklisted by U.S.By Ben Otto Chinese artificial intelligence giant SenseTime Group Inc. will postpone its initial public offering in Hong Kong after being added to a U.S....
Les mer »

China's SenseTime postpones $767 mln Hong Kong IPO after U.S. banChina's SenseTime postpones $767 mln Hong Kong IPO after U.S. banChinese artificial intelligence start-up SenseTime Group postponed its $767 million Hong Kong initial public offering (IPO) on Monday after being placed on a U.S. investment blacklist.
Les mer »



Render Time: 2025-03-29 11:20:21